A Study to Tailor Advance Directives
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
In this study, hospitalized patients will first be surveyed regarding their interest in a traditional advanced directive (AD) and then in a modified AD.
| Condition | Intervention |
|---|---|
|
Dementia Persistent Vegetative State Terminally Ill |
Behavioral: Advance Directive Selection |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | A Study to Tailor Advance Directives |
| Estimated Enrollment: | 100 |
| Study Start Date: | July 2005 |
| Study Completion Date: | September 2005 |
| Primary Completion Date: | September 2005 (Final data collection date for primary outcome measure) |
The purpose of this study is to assess whether patients will execute an advance directive which offers a limited trial of life-sustaining therapy in non-terminal illness, declines life-sustaining therapy or artificial nutrition in advanced dementia, or declines life-sustaining therapy in general. Advance directives (ADs) as currently drafted have been questioned since they have not had much effect on end-of-life care. However, the reason for the lack of success may be simply that they rarely apply. Traditional ADs, which are limited to terminal illness or persistent vegetative states, are difficult to apply to the more common cases of critical illness in the setting of potentially reversible disease and advanced dementia, which are often not recognized as terminal. In addition, terminal ADs are drafted too narrowly for patients who do not wish for life-sustaining therapy regardless of condition.
Patients may execute either AD at the conclusion of the survey. This research has the potential to demonstrate widely reproducible methods on which more precise advance planning can be based and thereby improve end-of-life care.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Hospitalized patients admitted to the general medical service at the University of Chicago
Inclusion Criteria:
- Hospitalized patients admitted to the general medical service at the University of Chicago
- Previously enrolled in a study of hospitalized general medicine patients at the University of Chicago
Exclusion Criteria:
- Patients who score less than 17 out of 30 on the Folstein Mini-Mental Status Examination or who have a proxy decision-maker
- Patients who are medically unstable based on two or more abnormal vital signs
- Patients who face a possible new diagnosis of cancer
Contacts and Locations| United States, Illinois | |
| The University of Chicago | |
| Chicago, Illinois, United States, 60637 | |
| Principal Investigator: | Elmer Abbo, M.D., Ph.D. | University of Chicago |
| Principal Investigator: | David Meltzer, M.D., Ph.D. | University of Chicago |
More Information
Publications:
| Responsible Party: | Elmer Abbo, M.D., Ph.D., The University of Chicago |
| ClinicalTrials.gov Identifier: | NCT00121004 History of Changes |
| Other Study ID Numbers: | 13787A |
| Study First Received: | July 11, 2005 |
| Last Updated: | February 26, 2010 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Chicago:
|
Advance Directive Living Will Terminal Illness |
Additional relevant MeSH terms:
|
Dementia Persistent Vegetative State Brain Diseases Central Nervous System Diseases Nervous System Diseases Delirium, Dementia, Amnestic, Cognitive Disorders Mental Disorders |
Brain Damage, Chronic Unconsciousness Consciousness Disorders Neurobehavioral Manifestations Neurologic Manifestations Signs and Symptoms |
ClinicalTrials.gov processed this record on October 16, 2012
